BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, January 6, 2026
Home
»
Authors
»
Aaron Lorenzo
Articles by Aaron Lorenzo
Peptimmune Gets License To Obesity Drug From Genzyme
May 11, 2004
By
Aaron Lorenzo
Celera Genomics Sells All Shares Of Discovery Partners For $36M
May 7, 2004
By
Aaron Lorenzo
Celera Genomics Sells All Shares Of Discovery Partners For $36M
May 7, 2004
By
Aaron Lorenzo
TriMed Focuses On Developing MAA Protein For Multiple Uses
May 6, 2004
By
Aaron Lorenzo
Biolex Grows MAb Capabilities Through Acquisition Of Epicyte
May 6, 2004
By
Aaron Lorenzo
Biolex Grows MAb Capabilities Through Acquisition Of Epicyte
May 6, 2004
By
Aaron Lorenzo
TriMed Focuses On Developing MAA Protein For Multiple Uses
May 6, 2004
By
Aaron Lorenzo
Axonyx Brings In Another $20M Through Sale Of Stock, Warrants
May 5, 2004
By
Aaron Lorenzo
Axonyx Brings In Another $20M Through Sale Of Stock, Warrants
May 5, 2004
By
Aaron Lorenzo
MannKind Registers For IPO To Support Diabetes Product
May 4, 2004
By
Aaron Lorenzo
Previous
1
2
…
145
146
147
148
149
150
151
152
153
…
237
238
Next
